Cargando…
Single cell characteristics of patients with vaccine-related adverse reactions following inactivated COVID-19 vaccination
A good safety and immunogenicity profile was reported in Phase I and II clinical trials of inactivated SARS-CoV-2 vaccines. Here, we report two cases associated with vaccine-associated adverse events, including one patient with fever and another with anaphylactic shock resulting from inactivated SAR...
Autores principales: | Jiang, Manling, Yu, Haiqiong, Luo, Li, Zhang, Lei, Xiong, Anying, Wang, Junyi, Wang, Qianhui, Liu, Yao, Liu, Shengbin, Xiong, Ying, Yang, Pingchang, Chang, Christopher, Zhang, Jianquan, He, Xiang, Li, Guoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453975/ https://www.ncbi.nlm.nih.gov/pubmed/37614152 http://dx.doi.org/10.1080/21645515.2023.2246542 |
Ejemplares similares
-
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
por: Ao, Ling, et al.
Publicado: (2022) -
Adverse reactions to inactivated COVID-19 vaccination in patients with chronic liver disease: The effect of anxiety
por: Lv, Li, et al.
Publicado: (2022) -
Assessing the transition of COVID-19 burden towards the young population while vaccines are rolled out in China*
por: Cai, Jun, et al.
Publicado: (2022) -
Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine
por: Yong, Xiaolan, et al.
Publicado: (2023) -
Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in Shanghai
por: Wu, Qianhui, et al.
Publicado: (2023)